SPRINT-TB Publishes Its 2016/2017 Annual Report
SPRINT-TB has released its Annual Report 2016/2017, the first of a planned yearly series that keeps the scientific community and wider public informed about the programme's work, updates and research breakthroughs. The programme began officially in July 2014, and within just over a year it had already generated a wide range of findings and achievements.
Among the standout results from SPRINT-TB's first year of formal operation, Theme 1 identified strong activity of bortezomib against a new M. tuberculosis target. In Theme 2, researchers have begun searching for bortezomib derivatives that could kill bacteria more selectively while causing minimal toxicity.
Theme 3 established a platform for testing new drugs and drug combinations in humans — the whole blood bactericidal activity assay — and adapted it so it can evaluate drugs that act on the bacteria as well as those that modify the host immune response. Theme 4 has launched a joint TB health services research effort with Cambodia's national TB programme and opened the SPRINT-TB office in Phnom Penh.
The SPRINT-TB Annual Report 2016/2017 is ready to download.
Download the Annual ReportExplore SPRINT-TB
- Theme 1: Target Discovery
- Theme 2: Drug Development
- Theme 3: Clinical Trials
- Theme 4: Treatment Delivery
Research News Events Journal Club Annual Symposium Giving Contact Contact Us Careers
News Archive
- September 2018
- December 2017
- March 2017
- December 2016
- September 2016
- March 2016
- February 2016
- December 2015
- November 2015
- October 2015
- September 2015
- July 2015
- May 2015
- April 2015
- March 2015
- February 2015
- November 2014
- October 2014
- September 2014
- July 2014
All Categories Comments Share